The investors in the audience gathered together in twos and threes to chat. Some were chatting like Young and Wang Hongbo, while others were chatting like friends about things unrelated to work.
Lei Jun walked to the front desk to speak in a blue shirt that he had worn countless times in public:
"Welcome everyone to the sharing session of Kechuang Biotech. As one of the shareholders of Kechuang Biotech, I am here to help Zheng Li warm up the atmosphere."
"It is said to be a sharing meeting. We do have something to share with you, but there is another layer that we want to introduce a second round of investment."
"Originally, when I was chatting with Zheng Li in private, I said that I would invest all of the second round of investment for you. Just tell me how much you want, and I will cover it all."
"Then Zheng Li took out a document and showed it to me, which is the document I will share with you today. After reading it, I fell silent because it was too expensive and I couldn't afford it."
After Lei Jun said this, the investors in the audience looked at each other. Even Lei Jun couldn't afford it. How high is the valuation of the second round of investment?
"And from another perspective, a company has more investors, which is conducive to the growth of the company."
"After all, the industries I have been engaged in have been mainly in the Internet industry, so the only thing I can provide in the biomedical industry is funds."
"A successful company cannot grow only by relying on capital. We need more investors to support its growth."
"We have sent invitations to everyone. Since you are willing to attend the sharing meeting of Science and Technology Biotech, I assume that you have the intention to invest."
“Many people in the audience are acquaintances, such as IDG, Qiming Venture Partners and Morningside Capital. These investment institutions all participated in Rice’s Series A investment. At that time, I went everywhere to meet investors, and the Series A investment only received 41 million. Dollar."
"When Zheng Li found me, he said he was a fan of mine who wanted to talk to me. I thought I was a little proud to have an 18-year-old fan who published a Nature paper, plus we are seniors and junior students."
"I just chatted with him, but something happened after we chatted. He took 50 million from me after half an hour's phone call, but the unit was RMB."
"I even wanted to give him some more money."
"For example, Liu Qin from Morningside Capital and I are old acquaintances. Morningside Capital previously only invested in Internet companies. Not long ago, Liu Qin asked me when will your second round of investment in Science and Technology Biotech start?"
"Can we also vote for some?"
"In addition, there have been too many investors who came to me recently because of this matter. Do they all express their lack of money? There must be a shortage of money for clinical trials in the second and third phases. Clinical trials in Europe and the United States are more expensive, and we need to invest some. Give you money?"
"This is really a trouble for happiness. Investors are rushing to send money. It reminds me of the days when Da Mira invested. I still feel a little sad. The seniors are not as good as the juniors."
"Getting back to the subject, after today's sharing session, everyone's desire to invest in scientific and innovative biotech products will definitely be stronger."
"Now let us welcome Zheng Li, chairman of Kechuang Biotechnology, to share with you the latest developments of the company."
At 3:35 in the afternoon, Zheng Li walked on stage after waiting for five minutes:
"Mr. Lei's speech was very good. I think everyone in the audience listened with great interest. What I said may be a lot boring."
After staying at Blue Star for almost a year, Zheng Lixin knew all the idioms at his fingertips.
"I believe everyone has a general understanding of endorphins. Today I will mainly introduce some things that everyone does not know."
“First of all, the synthesis cost of the industrialized synthesis route of endorphins is up to 20% higher than that of morphine, but its analgesic effect is ten times that of morphine.”
"But endorphins are far better at producing addiction than morphine or any of the opioid painkillers."
If you only look at the analgesic effect, the analgesic effect of fentanyl is 50-100 times that of morphine. And the synthesis cost of fentanyl is about the same as that of morphine.
But this thing is too addictive, no less addictive than heroin.
"Simply put, endorphins do not cause addiction when used in moderation, which is good news for all cancer patients."
"In addition, I have recently made a major discovery. Injection of endorphins and lipoprotein trypsin peptide at a certain dose ratio can effectively reduce the patient's dependence on opioids after a course of treatment."
"Including heroin and other opioid drugs."
As soon as he finished speaking, the investors in the audience were excited. This was an epic discovery. If it were true, Zheng Li would be more than enough to win the Nobel Prize for this.
You must know that on the subject of reducing addiction, countless scientists from academia to industry have made attempts over the years.
Whether it is at the drug level or the cognitive behavioral level, scientists have used countless methods but have not obtained a good solution.
More importantly, this means that there is hope for radical cure or alleviation of drug addiction. This market is extremely broad and is equivalent to a monopoly market.
Zheng Li saw that almost everyone in the audience raised their hands, with questions written all over their faces. He signaled: "The staff will hand the microphone to the lady at the front of the audience."
The woman at the front is Stephanie from Goldman Sachs. She goes straight to the point:
"Hello, Director Zheng. I'm sorry that my question may offend you a little. I want to apologize first."
“But I believe these questions are also questions for all of our investors present.”
"To what extent are endorphins effective in reducing a patient's addiction to opioids when taken in combination with another drug?"
Zheng Li replied: "We have achieved a radical cure in mice. As long as they are no longer exposed to opioids, they will not become dependent on opioids."
Stephanie looked in disbelief: "Are you telling the truth?"
Zheng Li solemnly said: "It's absolutely true!"
Stephanie: “I’m sorry this news is so shocking and I thank you on behalf of countless addicts.”
"But I still have to ask. Kechuang Biotechnology is about to conduct a second round of venture capital investment. Now that you have revealed to us this unprecedented benefit, I have some doubts about its authenticity."
"None of us want the Holmes incident to happen again. Holmes' company claimed to be able to test blood for cancer, but in the end it was found that the effect she claimed could not be achieved at all."
Stephanie was afraid that Zheng Li was young and didn't know who Elizabeth Holmes was.
"I'm not doubting you, I just want to confirm the authenticity of your message."
Zheng Li nodded and said: "I can understand your concerns. Regarding this discovery, I have written the experimental process and conclusions into a paper and sent it to The Lancet."
"The editor of The Lancet successfully reproduced the experiment and experimental results in mice after receiving the endorphins and lipotropic tryptic peptides I sent."
"The paper will be on the cover of the latest issue of The Lancet. You can also contact your trustworthy laboratory to reproduce the experimental steps contained in it."
